Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's disease
Fierce Pharma
With site 'irregularities,' BMS delays key Cobenfy readout
BMS investors have high hopes for Adept-2 given the size of the market opportunity and other late-stage clinical setbacks at the company.
Angus Liu
Dec 3, 2025 10:14am
Fierce Pharma
Novo reports 2 trial failures for GLP-1 in Alzheimer's disease
Nov 24, 2025 11:41am
J&J's anti-tau antibody posdinemab flops in phase 2
Nov 24, 2025 9:40am
Labcorp to carry Roche's FDA-cleared Alzheimer's blood test
Oct 24, 2025 8:45am
2 European biotechs link to tackle neurodegenerative diseases
Oct 20, 2025 8:20am
Roche nabs FDA clearance for Alzheimer's biomarker blood test
Oct 14, 2025 11:12am
